OLIG3 anticorps (Middle Region)
Aperçu rapide pour OLIG3 anticorps (Middle Region) (ABIN453775)
Antigène
Voir toutes OLIG3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- This antibody reacts to OLIG3.
-
Purification
- Affinity chromatography on Protein A
-
Immunogène
- KLH conjugated synthetic peptide selected from the Center region of human OLIG3
-
-
-
-
Indications d'application
-
ELISA: 1/1,000. Western blotting: 1/100 - 1/500.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- OLIG3 (Oligodendrocyte Transcription Factor 3 (OLIG3))
-
Autre désignation
- OLIG3
-
Sujet
- OLIG3 may determine the distinct specification program of class A neurons in the dorsal part of the spinal cord and suppress specification of class B neurons.Synonyms: BHLHB7, Class B basic helix-loop-helix protein 7, OLIG-3, Oligo3, Oligodendrocyte transcription factor 3, bHLHB7
-
ID gène
- 167826
-
NCBI Accession
- NP_786923
-
UniProt
- Q7RTU3
Antigène
-